The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Depleting Neuronal PrP in Prion Infection Prevents Disease and Reverses Spongiosis
Abstract
The mechanisms involved in prion neurotoxicity are unclear, and therapies preventing accumulation of PrP Sc , the disease-associated form of prion protein (PrP), do not significantly prolong survival in mice with central nervous system prion infection. We found that depleting endogenous neuronal PrP c in mice with established neuroinvasive prion infection reversed early spongiform change and prevented neuronal loss and progression to clinical disease. This occurred despite the accumulation of extraneuronal PrP Sc to levels seen in terminally ill wild-type animals. Thus, the propagation of nonneuronal PrP Sc is not pathogenic, but arresting the continued conversion of PrP c to PrP Sc within neurons during scrapie infection prevents prion neurotoxicity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mice devoid of PrP are resistant to scrapie
Büeler, H., Aguzzi, A., Sailer, A., Greiner, R.-A., Autenried, P., Aguet, M., & Weissmann, C. (1993) · Cell · doi:10.1016/0092-8674(93)90360-3 · Cited by 2,100
Eight prion strains have PrPSc molecules with different conformations
Safar, J., Wille, H., Itri, V., Groth, D., Serban, H., Torchia, M., Cohen, F. E., & Prusiner, S. B. (1998) · Nature Medicine · doi:10.1038/2654 · Cited by 1,245
Site-specific DNA recombination in mammalian cells by the Cre recombinase of bacteriophage P1.
Sauer, B., & Henderson, N. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.14.5166 · Cited by 1,213
Fischer, M., Rülicke, T., Raeber, A., Sailer, A., Moser, M., Oesch, B., Brandner, S., Aguzzi, A., & Weissmann, C. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00467.x · Cited by 877
Self-citationNormal host prion protein necessary for scrapie-induced neurotoxicity
Brandner, S., Isenmann, S., Raeber, A., Fischer, M., Sailer, A., Kobayashi, Y., Marino, S., Weissmann, C., & Aguzzi, A. (1996) · Nature · doi:10.1038/379339a0 · Cited by 810
Self-citationMallucci, G. R., Ratté, S., Asante, E. A., Linehan, J., Gowland, I., Jefferys, J. G. R., & Collinge, J. (2002) · The EMBO Journal · doi:10.1093/emboj/21.3.202 · Cited by 393
Self-citationAsante, E. A. (2002) · The EMBO Journal · doi:10.1093/emboj/cdf653 · Cited by 357
Porphyrin and Phthalocyanine Antiscrapie Compounds
Priola, S. A., Raines, A., & Caughey, W. S. (2000) · Science · doi:10.1126/science.287.5457.1503 · Cited by 302
Species-barrier-independent prion replication in apparently resistant species
Hill, A. F., Joiner, S., Linehan, J., Desbruslais, M., Lantos, P. L., & Collinge, J. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.18.10248 · Cited by 295
Self-citationNo propagation of prions in mice devoid of PrP
Sailer, A. (1994) · Cell · doi:10.1016/0092-8674(94)90436-7 · Cited by 285
Manson, J. C., Clarke, A. R., McBride, P., McConnell, I., & Hope, J. E. (1994) · PubMed · Cited by 262
Prion diseases of humans and animals
Prusiner, S. B., Telling, G., Cohen, F. E., & DeArmond, S. J. (1996) · Seminars in Virology · doi:10.1006/smvy.1996.0021 · Cited by 234
Raeber, A. J. (1997) · The EMBO Journal · doi:10.1093/emboj/16.20.6057 · Cited by 210
Effectiveness of Anthracycline Against Experimental Prion Disease in Syrian Hamsters
Tagliavini, F., McArthur, R. A., Canciani, B., Giaccone, G., Porro, M., Bugiani, M., Lievens, P. M.-J., Bugiani, O., Peri, E., Dall’Ara, P., et al. (1997) · Science · doi:10.1126/science.276.5315.1119 · Cited by 176
Doxycycline control of prion protein transgene expression modulates prion disease in mice
Tremblay, P., Meiner, Z., Galou, M., Heinrich, C., Petromilli, C., Lisse, T., Cayetano, J., Torchia, M., Mobley, W., Bujard, H., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.21.12580 · Cited by 172
Transmission of fatal familial insomnia to laboratory animals
Collinge, J., Palmer, M. S., Sidle, K. C. L., Gowland, I., Medori, R., Ironside, J. W., & Lantos, P. L. (1995) · The Lancet · doi:10.1016/s0140-6736(95)91405-6 · Cited by 156
Self-citationBaker, C. A., Martin, D., & Manuelidis, L. (2002) · Journal of Virology · doi:10.1128/jvi.76.21.10905-10913.2002 · Cited by 128
Neuropathologic findings associated with seizures in FVB mice.
Goelz, M. F., MAHLER, J. F., Harry, J. L., Myers, P. C., Clark, J., Thigpen, J. E., & Forsythe, D. B. (1998) · PubMed · Cited by 89
Microglial Activation Varies in Different Models of Creutzfeldt-Jakob Disease
Baker, C. A., Lu, Z. Y., Zaitsev, I. V., & Manuelidis, L. (1999) · Journal of Virology · doi:10.1128/jvi.73.6.5089-5097.1999 · Cited by 89
Interventional strategies against prion diseases
Aguzzi, A., Glatzel, M., Montrasio, F., Prinz, M., & Heppner, F. L. (2001) · Nature reviews. Neuroscience · doi:10.1038/35094590 · Cited by 83
Cited by
A General Model of Prion Strains and Their Pathogenicity
Collinge, J., & Clarke, A. R. (2007) · Science · doi:10.1126/science.1138718 · Cited by 1,057
Self-citationNon–cell autonomous toxicity in neurodegenerative disorders: ALS and beyond
Ilieva, H., Polymenidou, M., & Cleveland, D. W. (2009) · Journal of Cell Biology · doi:10.1083/jcb.200908164 · Cited by 1,008
Protein aggregation diseases: pathogenicity and therapeutic perspectives
Aguzzi, A., & O'Connor, T. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3050 · Cited by 762
Anchorless Prion Protein Results in Infectious Amyloid Disease Without Clinical Scrapie
Chesebro, B., Trifilo, M., Race, R., Meade-White, K., Teng, C., LaCasse, R., Raymond, L., Favara, C., Baron, G., Priola, S., et al. (2005) · Science · doi:10.1126/science.1110837 · Cited by 652
Physiology of the prion protein
Linden, R., Martins, V. R., Prado, M. A. M., Cammarota, M., Izquierdo, I., & Brentani, R. R. (2008) · Physiological Reviews · doi:10.1152/physrev.00007.2007 · Cited by 617
Metadata
- Authors
- Mallucci, G., Dickinson, A., Linehan, J., Klöhn, P.-C., Brandner, S., & Collinge, J.
- Venue
- Science
- Published
- 2003-10-31
- Volume
- 302
- Issue
- 5646
- Pages
- 871-874
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2000966016
- Cited by
- 770
- References
- 20
- FWCI
- 14.48
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.